A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.

R RuppD HurleyS GraysonJ LiKatrina M NolanR D McFetridgeJ HartzelC AbeygunawardanaM WintersH PujarP BennerL Musey

Published in: Human vaccines & immunotherapeutics (2019)

PCV15 is safe and induces IgG and OPA responses to all 15 serotypes in the vaccine. No significant differences in antibody responses were observed with increases in PnPs and/or Aluminum Phosphate Adjuvant.

Keyphrases

early stage
cancer therapy